메뉴 건너뛰기




Volumn 27, Issue 4, 2006, Pages 257-266

Gene doping

Author keywords

Doping; Epo; Gene therapy; IGF

Indexed keywords

ACTIVIN RECEPTOR 2; COMPLEMENTARY DNA; DNA; ENDORPHIN DERIVATIVE; ENKEPHALIN; ERYTHROPOIETIN; FOLLISTATIN; FOMIVIRSEN; GENDICINE; MYOSTATIN; PROTEIN P53; RECOMBINANT ERYTHROPOIETIN; SOMATOMEDIN C; VASCULOTROPIN;

EID: 33645689379     PISSN: 01724622     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-923986     Document Type: Review
Times cited : (70)

References (42)
  • 3
    • 0034265759 scopus 로고    scopus 로고
    • Muscle, genes and athletic performance
    • Andersen JL, Schjerling P, Saltin B. Muscle, genes and athletic performance. Sci Am 2000; 283: 48-55
    • (2000) Sci Am , vol.283 , pp. 48-55
    • Andersen, J.L.1    Schjerling, P.2    Saltin, B.3
  • 6
    • 0032416479 scopus 로고    scopus 로고
    • Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function
    • Barton-Davis ER, Shoturma DI, Musaro A, Rosenthal N, Sweeney HL. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci USA 1998; 95: 15603-15607
    • (1998) Proc Natl Acad Sci USA , vol.95 , pp. 15603-15607
    • Barton-Davis, E.R.1    Shoturma, D.I.2    Musaro, A.3    Rosenthal, N.4    Sweeney, H.L.5
  • 7
    • 0032583951 scopus 로고    scopus 로고
    • Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
    • Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M, Walsh K, Isner JM. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circul 1998; 97: 1114-1123
    • (1998) Circul , vol.97 , pp. 1114-1123
    • Baumgartner, I.1    Pieczek, A.2    Manor, O.3    Blair, R.4    Kearney, M.5    Walsh, K.6    Isner, J.M.7
  • 9
    • 10944271807 scopus 로고    scopus 로고
    • Efficacy of gene therapy for SCID is being confirmed
    • Cavazzana-Calvo M, Fischer A. Efficacy of gene therapy for SCID is being confirmed. Lancet 2004; 364: 2155-2156
    • (2004) Lancet , vol.364 , pp. 2155-2156
    • Cavazzana-Calvo, M.1    Fischer, A.2
  • 13
    • 4444268850 scopus 로고    scopus 로고
    • The faking of champions
    • DeFrancesco L. The faking of champions. Nat Biotechnol 2004; 22: 1069-1071
    • (2004) Nat Biotechnol , vol.22 , pp. 1069-1071
    • DeFrancesco, L.1
  • 18
    • 0346906569 scopus 로고    scopus 로고
    • Gene therapy and tissue engineering for sports medicine
    • Huard J, Li Y, Peng H, Fu FH. Gene therapy and tissue engineering for sports medicine. J Gene Med 2003; 5: 93-108
    • (2003) J Gene Med , vol.5 , pp. 93-108
    • Huard, J.1    Li, Y.2    Peng, H.3    Fu, F.H.4
  • 20
    • 11844303500 scopus 로고    scopus 로고
    • Recent developments in gene transfer: Risk and ethics
    • Kimmelman J. Recent developments in gene transfer: risk and ethics. BMJ 2005; 330: 79-82
    • (2005) BMJ , vol.330 , pp. 79-82
    • Kimmelman, J.1
  • 22
    • 34547493681 scopus 로고    scopus 로고
    • Cyclist's doping associated with cerebral sinus thrombosis
    • Lage JM, Panizo C, Masdeu J, Rocha E. Cyclist's doping associated with cerebral sinus thrombosis. Neurol 2002; 58: 665
    • (2002) Neurol , vol.58 , pp. 665
    • Lage, J.M.1    Panizo, C.2    Masdeu, J.3    Rocha, E.4
  • 24
    • 1342325478 scopus 로고    scopus 로고
    • Viral expression of insulin-like growth factor-I enhances muscle hypertrophy in resistance-trained rats
    • Lee S, Barton ER, Sweeney HL, Farrar RP. Viral expression of insulin-like growth factor-I enhances muscle hypertrophy in resistance-trained rats. J Appl Physiol 2004; 96: 1097-1104
    • (2004) J Appl Physiol , vol.96 , pp. 1097-1104
    • Lee, S.1    Barton, E.R.2    Sweeney, H.L.3    Farrar, R.P.4
  • 25
    • 0035979253 scopus 로고    scopus 로고
    • Regulation of myostatin activity and muscle growth
    • Lee SJ, McPherron AC. Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA 2001; 98: 9306-9311
    • (2001) Proc Natl Acad Sci USA , vol.98 , pp. 9306-9311
    • Lee, S.J.1    McPherron, A.C.2
  • 27
    • 0037197740 scopus 로고    scopus 로고
    • Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia
    • Losordo DW, Vale PR, Hendel RC, Milliken CE, Fortuin FD, Cummings N, Schatz RA, Asahara T, Isner JM, Kuntz RE. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circul 2002; 105: 2012-2018
    • (2002) Circul , vol.105 , pp. 2012-2018
    • Losordo, D.W.1    Vale, P.R.2    Hendel, R.C.3    Milliken, C.E.4    Fortuin, F.D.5    Cummings, N.6    Schatz, R.A.7    Asahara, T.8    Isner, J.M.9    Kuntz, R.E.10
  • 28
    • 14644435182 scopus 로고    scopus 로고
    • The growth factor myostatin, a key regulator in skeletal muscle growth and homeostasis
    • Matsakas A, Diel P. The growth factor myostatin, a key regulator in skeletal muscle growth and homeostasis. Int J Sports Med 2005; 26: 83-89
    • (2005) Int J Sports Med , vol.26 , pp. 83-89
    • Matsakas, A.1    Diel, P.2
  • 31
    • 0142023866 scopus 로고    scopus 로고
    • Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: A phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication
    • Rajagopalan S, Mohler ER, III, Lederman RJ, Mendelsohn FO, Saucedo JF, Goldman CK, Blebea J, Macko J, Kessler PD, Rasmussen HS, Annex BH. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circul 2003; 108: 1933-1938
    • (2003) Circul , vol.108 , pp. 1933-1938
    • Rajagopalan, S.1    Mohler III, E.R.2    Lederman, R.J.3    Mendelsohn, F.O.4    Saucedo, J.F.5    Goldman, C.K.6    Blebea, J.7    Macko, J.8    Kessler, P.D.9    Rasmussen, H.S.10    Annex, B.H.11
  • 33
    • 0142089747 scopus 로고    scopus 로고
    • Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer
    • Raper SE, Chirmule N, Lee FS, Wivel NA, Bagg A, Gao GP, Wilson JM, Batshaw ML. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 2003; 80: 148-158
    • (2003) Mol Genet Metab , vol.80 , pp. 148-158
    • Raper, S.E.1    Chirmule, N.2    Lee, F.S.3    Wivel, N.A.4    Bagg, A.5    Gao, G.P.6    Wilson, J.M.7    Batshaw, M.L.8
  • 35
    • 0033522939 scopus 로고    scopus 로고
    • Nota bene: Biomedicine. Pain-killer genes
    • Smith O. Nota bene: biomedicine. Pain-killer genes. Sci 1999; 284: 1634
    • (1999) Sci , vol.284 , pp. 1634
    • Smith, O.1
  • 36
    • 2142751261 scopus 로고    scopus 로고
    • Evaluation of risks related to the use of adeno-associated virus-based vectors
    • Tenenbaum L, Lehtonen E, Monahan PE. Evaluation of risks related to the use of adeno-associated virus-based vectors. Curr Gene Ther 2003; 3: 545-565
    • (2003) Curr Gene Ther , vol.3 , pp. 545-565
    • Tenenbaum, L.1    Lehtonen, E.2    Monahan, P.E.3
  • 37
    • 27544465879 scopus 로고    scopus 로고
    • Functional characteristics of coronary vasomotor function following intramyocardial gene therapy with naked DNA encoding for vascular endothelial growth factor 165
    • Tio RA, Wijpkema JS, Tan ES, Asselbergs FW, Hospers GA, Jessurun GA, Zijlstra F. Functional characteristics of coronary vasomotor function following intramyocardial gene therapy with naked DNA encoding for vascular endothelial growth factor 165. Endothelium 2005; 12: 103-106
    • (2005) Endothelium , vol.12 , pp. 103-106
    • Tio, R.A.1    Wijpkema, J.S.2    Tan, E.S.3    Asselbergs, F.W.4    Hospers, G.A.5    Jessurun, G.A.6    Zijlstra, F.7
  • 38
    • 0036202668 scopus 로고    scopus 로고
    • A randomized controlled clinical trial of intravitreous fomivirsen for treatment of newly diagnosed peripheral cytomegalovirus retinitis in patients with AIDS
    • Vitravene Study Group. A randomized controlled clinical trial of intravitreous fomivirsen for treatment of newly diagnosed peripheral cytomegalovirus retinitis in patients with AIDS. Am J Ophthalmol 2002; 133: 467-474
    • (2002) Am J Ophthalmol , vol.133 , pp. 467-474
  • 40
    • 0036280779 scopus 로고    scopus 로고
    • Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry
    • Wu W, Tang X, Hu W, Lotan R, Hong WK, Mao L. Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry. Clin Exp Metastasis 2002; 19: 319-326
    • (2002) Clin Exp Metastasis , vol.19 , pp. 319-326
    • Wu, W.1    Tang, X.2    Hu, W.3    Lotan, R.4    Hong, W.K.5    Mao, L.6
  • 42
    • 0031834034 scopus 로고    scopus 로고
    • Adeno-associated virus-mediated delivery of erythropoietin leads to sustained elevation of hematocrit in nonhuman primates
    • Zhou S, Murphy JE, Escobedo JA, Dwarki VJ. Adeno-associated virus-mediated delivery of erythropoietin leads to sustained elevation of hematocrit in nonhuman primates. Gene Ther 1998; 5: 665-670
    • (1998) Gene Ther , vol.5 , pp. 665-670
    • Zhou, S.1    Murphy, J.E.2    Escobedo, J.A.3    Dwarki, V.J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.